Medications for Granulomatosis With Polyangiitis

3 results
  • rituxan - rituximab injection, solution

    (Rituximab)
    Genentech, Inc.
    Rituxan treats Non-Hodgkin's Lymphoma (adults and pediatric patients 6+ months), Chronic Lymphocytic Leukemia, moderately-to-severely active Rheumatoid Arthritis unresponsive to TNF antagonists, Granulomatosis with Polyangiitis and Microscopic Polyangiitis (ages 2+), and moderate-to-severe Pemphigus Vulgaris in adults.
  • ruxience - rituximab - pvvr injection, solution

    (Rituximab-Pvvr)
    Pfizer Laboratories Div Pfizer Inc
    Ruxience treats adult patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, moderately-to-severely active Rheumatoid Arthritis (after TNF antagonist failure), Granulomatosis with Polyangiitis, Microscopic Polyangiitis, and moderate-to-severe Pemphigus Vulgaris.
  • tavneos - avacopan capsule

    (Avacopan)
    Chemocentryx, Inc.
    TAVNEOS is indicated as adjunctive treatment for adults with severe active ANCA-associated vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis), used in combination with standard therapy including glucocorticoids.